Patients News | pharmaphorum

News

New cystic fibrosis triple from Vertex backed for NHS use

Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.

News

Three Apple watches in black, brown, and pink

Paper gives hint of Apple's thinking on AI and health

Apple is looking at combining AI and behavioural measurements in its health apps, but will the tech make it to a consumer device like the Apple Watch?

News

'Diabetes Barbie' launches with medtech accessories

Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.

News

UK authority cracks down on weight-loss drug ads

Nine adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting prescription-only drugs.

News

US measles elimination status at risk as cases soar

Measles cases are roaring back in the US, with nearly 1,300 cases so far this year, 25 years after the disease was declared eliminated by the CDC.

News

NICE backs new drugs for Crohn's disease, lymphoma

Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.

New cystic fibrosis triple from Vertex backed for NHS use

Paper gives hint of Apple's thinking on AI and health

'Diabetes Barbie' launches with medtech accessories

UK authority cracks down on weight-loss drug ads

US measles elimination status at risk as cases soar

NICE backs new drugs for Crohn's disease, lymphoma

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks